| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |